Actor
portrayal
A 2023 Arcutis survey of 93 adults diagnosed with seborrheic dermatitis found that an average of 15 products (including over-the-counter, alternative, and prescription treatments) were reportedly used on a yearly basis.2
Effectively control seborrheic dermatitis and simplify treatment with a steroid-free foam.1
.
Once a day.
Anywhere.1
ZORYVE is for topical use only and not for ophthalmic, oral, or intravaginal use.1
A 2023 Arcutis survey of 93 adults diagnosed with seborrheic dermatitis found that an average of 15 products (including over-the-counter, alternative, and prescription treatments) were reportedly used on a yearly basis.2
Actor portrayal
ZORYVE (zor-EEV) is a steroid-free, once-daily foam designed to simplify seborrheic dermatitis control1
DRAMATIC 77% IGA SUCCESS AT WEEK 8, RESULTS AS EARLY AS WEEK 21-3*
SEE RESULTSTOLERABLE AND SAFE, FOR ANY LOCATION AND DURATION1,3
REVIEW SAFETY PROFILEONCE-DAILY, STEROID-FREE FOAM FOR ALL SKIN AND HAIR TYPES1
DISCOVER ONCE-DAILY FOAM*Trial 203 and STRATUM studies evaluated ZORYVE (n=458) vs vehicle (n=225) once daily for 8 weeks in patients with seborrheic dermatitis. The primary endpoint was IGA Success at Week 8, defined as a score of Clear (0) or Almost Clear (1) and a ≥2-grade improvement from baseline.
IGA = Investigator Global Assessment.
ZORYVE foam has the potential to become the standard of care for seborrheic dermatitis.”
—Arcutis Chief Medical Officer Patrick Burnett, MD, PhD, FAAD
Actor portrayal